Search Results

Semiconductor Research Corporation, a premier research and workforce development consortium, is announcing the launch of solicitation season.

As part of the Semiconductor Research Corporation (SRC) being selected by NIST’s Advanced Manufacturing Office to define the future of Microelectronics and Advanced Packaging Technology (MAPT), Cardea Bio has been invited as a commercial semiconductor company to share their experience with integrating biology with electronics.

At some point in your research career, you may find yourself transitioning from academia to industry or vice versa. To best set yourself up for success, adapt your approach to the specific scientific culture where you work.

Having seen Congress spend money to onshore semiconductor production, pharma groups are pushing for similar incentives for domestic drug manufacturing.

One way Takeda lives out its values is by striving to ensure that patients are aware of and can access the company’s clinical trials. Two employees from its research and development organization discuss why representation matters and the work their team is doing to benefit patients now and in the future.

As clinical research evolves, disruptive trial designs are reshaping how oncology advances. By integrating novel methodologies, strategic innovation, and patient-centered approaches, MEDSIR is driving a new era in cancer research, one that accelerates development, enhances efficiency, and delivers more meaningful therapeutic progress for patients worldwide.

Semiconductor Research Corporation (SRC), a leading global semiconductor research consortium, today announced the appointment of industry veteran Todd Younkin as President and Chief Executive Officer. Younkin’s appointment was made by SRC’s Board of Directors. Younkin will start transitioning to his new role on August 18, 2020.